News

Congress criticises drugs industry for misleading advertising

BMJ 2002; 325 doi: 10.1136/bmj.325.7377.1379/a (Published 14 December 2002)
Cite this as: BMJ 2002;325:1379.2

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Scott Gottlieb
  1. New York

    Some companies have disseminated misleading advertisements for prescription drugs, even after being cited for violations, a report issued by the US Congress says.

    Congressional investigators, from the independent General Accounting Office, also said that drug advertising seemed to produce a major increase in the use of prescription drugs. The study estimated that at least 8.5 million Americans each year request and receive …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular